These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 19587645)
1. Sanofi Aventis grooms its ranks for biotech partnering. Moran N Nat Biotechnol; 2009 Jul; 27(7):581-2. PubMed ID: 19587645 [No Abstract] [Full Text] [Related]
2. Millennium and Aventis in unique pact. Fletcher L Nat Biotechnol; 2000 Aug; 18(8):817. PubMed ID: 10932140 [No Abstract] [Full Text] [Related]
3. Biotech battle royale. Two firms fight over billion-dollar drug. Sherrid P US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209 [No Abstract] [Full Text] [Related]
4. Genzyme-Sanofi buy out is second largest biotech deal ever. Ratner M Nat Biotechnol; 2011 Apr; 29(4):293-4. PubMed ID: 21478828 [No Abstract] [Full Text] [Related]
5. Genzyme deal set to alter biotech landscape. Ledford H Nature; 2011 Feb; 470(7335):449. PubMed ID: 21350458 [No Abstract] [Full Text] [Related]
7. Biotech industry faces new bottleneck. Garber K Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516 [No Abstract] [Full Text] [Related]
8. Hatteras rounds up $90 million to lead biotech rebound in North Carolina. Erickson D Nat Biotechnol; 2015 Nov; 33(11):1121-2. PubMed ID: 26544128 [No Abstract] [Full Text] [Related]
9. Swooping for biotech. Wadman M Nature; 2005 Sep; 437(7058):475. PubMed ID: 16177760 [No Abstract] [Full Text] [Related]